Gilead Sciences | Resultat Før Skat


Pre Tax Profit Lave om
Alexion Pharmaceuticals ALXN:US $ 827.7M 41M
Alnylam Pharmaceuticals ALNY:US $ -252.45M 74.23M
Amgen AMGN:US $ 2918M 77M
Biomarin Pharmaceutical BMRN:US $ -15.97M 117.32M
Bluebird Bio BLUE:US $ -21.46M 181.06M
Bristol Myers Squibb BMY:US $ 4357M 361M
Eli Lilly And LLY:US $ 1988.3M 137.6M
Gilead Sciences GILD:US $ 1804M 845M
GlaxoSmithKline GSK:LN 1541M 956M
Glaxosmithkline GSK:US $ 3200.86M 1288.28M
Intercept Pharmaceuticals ICPT:US $ -63.28M 29.7M
Johnson & Johnson JNJ:US $ 7246M 1909M
Merk MRK:US $ 4096M 510M
Neurocrine Biosciences NBIX:US $ 83M 45M
Pfizer PFE:US $ 5152M 170M
Ptc Therapeutics PTCT:US $ -170.73M 58.26M
Regeneron Pharmaceuticals REGN:US $ 876M 24.6M
Sanofi SAN:FP € 2054M 276M
Sarepta Therapeutics SRPT:US $ -151M 133M
Teva Pharmaceutical Industries TEVA:US $ 643M 106M
United Therapeutics UTHR:US $ 133.9M 37.7M
Vertex Pharmaceuticals VRTX:US $ 870.63M 11.79M
YTE INCY:US $ 292.96M 894.15M



Gilead Sciences Resultat Før Skat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Jan 2021.